Pregnancy in women with mechanical prosthetic heart valves is associated with an increased risk of maternal and fetal complications. Managing of the anticoagulation of these patients is very important for life saving ...Pregnancy in women with mechanical prosthetic heart valves is associated with an increased risk of maternal and fetal complications. Managing of the anticoagulation of these patients is very important for life saving of mother and fetus. Unfortunately, throm- boembolic complications in some pregnant women with mechanical mitral valve can be seen. Herein, we present urgent mechanical mitral valve replacement in a 27 year old pregnant woman due to stuck mecha- nical valve.展开更多
Coronary embolism has been considered as a rare cause of coronary occlusion. Prosthetic heart valve is an infrequent cause of this condition. The exact incidence of coronary embolization in patients with prosthetic he...Coronary embolism has been considered as a rare cause of coronary occlusion. Prosthetic heart valve is an infrequent cause of this condition. The exact incidence of coronary embolization in patients with prosthetic heart valves is not well known. Furthermore, the effective treatment and management of coronary emboli in this setting remains unknown. It is the purpose of this paper to report the successful management of a case of coronary embolism with half-dose tissue-type plasminogen activator （tPA） and tirofiban given intravenously in a patient with initial valve prosthesis.展开更多
文摘Pregnancy in women with mechanical prosthetic heart valves is associated with an increased risk of maternal and fetal complications. Managing of the anticoagulation of these patients is very important for life saving of mother and fetus. Unfortunately, throm- boembolic complications in some pregnant women with mechanical mitral valve can be seen. Herein, we present urgent mechanical mitral valve replacement in a 27 year old pregnant woman due to stuck mecha- nical valve.
文摘Coronary embolism has been considered as a rare cause of coronary occlusion. Prosthetic heart valve is an infrequent cause of this condition. The exact incidence of coronary embolization in patients with prosthetic heart valves is not well known. Furthermore, the effective treatment and management of coronary emboli in this setting remains unknown. It is the purpose of this paper to report the successful management of a case of coronary embolism with half-dose tissue-type plasminogen activator （tPA） and tirofiban given intravenously in a patient with initial valve prosthesis.
